The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma
May 04, 2026
May 04, 2026
HOUSTON, Texas, May 4 -- Rice University posted the following news release:
* * *
The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma
*
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs and seen as powerful new tools that can help people los . . .
* * *
The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma
*
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs and seen as powerful new tools that can help people los . . .